Central nicotinic receptor ligands and pharmacophores
- 作者Richard A Glennon; Małgorzata Dukat
- 卷第74卷
- 印刷ISSN0031-6865
- 文件大小277.58KB
- 发表时间2000
- DOI10.1016/s0031-6865(99)00022-9
- 页码103-114
Pharmacokinetic and pharmacodynamic evaluation of tigecyclineGiamarellou, Helen; Poulakou, Garyphallia · 2011
Pharmacokinetic and pharmacodynamic evaluation of the lantibiotic MU1140Oliver Ghobrial; Hartmut Derendorf; Jeffrey D. Hillman · 2010
Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metforminScheen, André J · Expert Opinion on Drug Metabolism & Toxicology · 2010
Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamilMerker, Andrew; Danziger, Larry H; Rodvold, Keith A; Glowacki, Robert C · Expert Opinion on Drug Metabolism & Toxicology · 2014
Pharmacokinetic and pharmacodynamic evaluation of liposomal cyclosporineVadiei, Kiumars; Perez-Soler, Roman; Lopez-Berestein, Gabriel; Luke, David R. · International Journal of Pharmaceutics · 1989
Cocrystals of Hesperetin: Structural, Pharmacokinetic, and Pharmacodynamic EvaluationChadha, Kunal; Karan, Maninder; Bhalla, Yashika; Chadha, Renu; Khullar, Sadhika; Mandal, Sanjay; Vasisht, Karan · Crystal Growth & Design · 2017
Pharmacokinetic and pharmacodynamic evaluation of ramelteon: an insomnia therapySpadoni, Gilberto; Bedini, Annalida; Lucarini, Simone; Mor, Marco; Rivara, Silvia · Expert Opinion on Drug Metabolism & Toxicology · 2015